Health
BioMérieux SARS-CoV-2 Serology Tests Granted FDA Emergency Use Authorization – HospiMedica
BioMérieux’s (Marcy-l’Étoile, France) has been granted Emergency Use Authorizations (EUAs) by the US Food and Drug Administration (FDA) for two SARS-CoV-2 serology tests.
BioMérieuxs (Marcy-l’Étoile, France) has been granted Emergency Use Authorizations (EUAs) by the US Food and Drug Administration (FDA) for two SARS-CoV-2 serology tests.The FDA has granted EUA to BioMérieuxs VIDAS SARS-COV-2 IgM and VIDAS SARS-COV-2 IgG automated qualitative assays which rapidly detect antibodies to help identify individuals with previous exposure to SARS-CoV-2. With the same protocols to differentiate IgM and IgG results, the VIDAS SARS-COV-2 IgM detects IgM specific for SARS-C…
-
Noosa News21 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News22 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General22 hours agoLabor to squeeze public service, sparking warnings of job losses
-
General21 hours ago‘World-first’ deal to give delivery drivers better pay